Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 2
Submit an article Journal homepage
1,679
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Centromere protein U (CENPU) promotes gastric cancer cell proliferation and glycolysis by regulating high mobility group box 2 (HMGB2)

Taozhi Denga Department of Gastroenterology, Hainan Cancer Hospital, Haikou, Hainan Province, ChinaCorrespondence[email protected]
View further author information
,
Xuemei Jiangb Department of Gastroenterology, Hainan General Hospital, Haikou, Hainan Province, ChinaView further author information
,
Zhoutao Heb Department of Gastroenterology, Hainan General Hospital, Haikou, Hainan Province, ChinaView further author information
,
Manni Caib Department of Gastroenterology, Hainan General Hospital, Haikou, Hainan Province, ChinaView further author information
,
Chaochao Chenb Department of Gastroenterology, Hainan General Hospital, Haikou, Hainan Province, ChinaView further author information
&
Zewen Xub Department of Gastroenterology, Hainan General Hospital, Haikou, Hainan Province, ChinaView further author information
Pages 10194-10202 | Received 30 Aug 2021, Accepted 21 Oct 2021, Published online: 07 Dec 2021

References

  • Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893–1907.
  • Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700–713.
  • Den Hoed CM, Kuipers EJ. Gastric cancer: how can we reduce the incidence of this disease? Curr Gastroenterol Rep. 2016;18(7):34.
  • Zhang B, Wu J, Cai Y, et al. AAED1 modulates proliferation and glycolysis in gastric cancer. Oncol Rep. 2018;40(2):1156–1164.
  • Guo L. Mitochondria and the permeability transition pore in cancer metabolic reprogramming. Biochem Pharmacol. 2021;188:114537.
  • Yang H, Li Y, Hu B. Potential role of mitochondria in gastric cancer detection: fission and glycolysis. Oncol Lett. 2021;21(6):439.
  • Liberti MV, Locasale JW. The warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211–218.
  • Hsu PP, Sabatini DM. Cancer cell metabolism: warburg and beyond. Cell. 2008;134(5):703–707.
  • Ganapathy-Kanniappan S, Geschwind J-FH. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12(1):1–11.
  • Pallier C, Scaffidi P, Chopineau-Proust S, et al. Association of chromatin proteins high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes. Mol Biol Cell. 2003;14(8):3414–3426.
  • Han X, Zhong S, Zhang P, et al. Identification of differentially expressed proteins and clinicopathological significance of HMGB2 in cervical cancer. Clin Proteomics. 2021;18(1):2.
  • Cui G, Cai F, Ding Z, et al. HMGB2 promotes the malignancy of human gastric cancer and indicates poor survival outcome. Hum Pathol. 2019;84:133–141.
  • Wang X, Chen D, Gao J, et al. Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival. Cancer Manag Res. 2018;10:6971–6984.
  • Li J, Wang ZG, Pang LB, et al. Reduced CENPU expression inhibits lung adenocarcinoma cell proliferation and migration through PI3K/AKT signaling. Biosci Biotechnol Biochem. 2019;83(6):1077–1084.
  • Pan H-Y, Zhang Y-J, Wang X-P, et al. Identification of a novel cellular transcriptional repressor interacting with the latent nuclear antigen of Kaposi’s sarcoma-associated herpesvirus. J Virol. 2003;77(18):9758–9768.
  • Li H, Zhang H, Wang Y. Centromere protein U facilitates metastasis of ovarian cancer cells by targeting high mobility group box 2 expression. Am J Cancer Res. 2018;8(5):835.
  • Zhang H, Tang J, Li C, et al. MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells. Cancer Lett. 2015;356(2Pt B):781–790.
  • Caracciolo D, Di Martino MT, Amodio N, et al. miR-22 suppresses DNA ligase III addiction in multiple myeloma. Leukemia. 2019;33(2):487–498.
  • Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101–1108.
  • Re-assembled Casein Micelles for Oral Delivery of Chemotherapeutic Combinations to Overcome Multidrug Resistance in Gastric Cancer. J Mol Clin Med. 2018;12
  • Scholzen T, Gerdes J. The Ki‐67 protein: from the known and the unknown. J Cell Physiol. 2000;182(3):311–322.
  • Agathocleous M, Harris WA. Metabolism in physiological cell proliferation and differentiation. Trends Cell Biol. 2013;23(10):484–492.
  • Liu Y, Zhang Z, Wang J, et al. Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review. Onco Targets Ther. 2019;12:1195–1204.
  • Zhang T-B, Zhao Y, Tong Z-X, et al. Inhibition of glucose-transporter 1 (GLUT-1) expression reversed Warburg effect in gastric cancer cell MKN45. Int J Clin Exp Med. 2015;8(2):2423.
  • Ding N, Xu S, Zheng S, et al. “Sweet tooth”-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy. J Mat Chem B. 2021;9(12):2816–2830.
  • Wu J, Zhang X, Wang Y, et al. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway. Oncol Rep. 2018;39(3):1181–1190.
  • Shao M, Zhang J, Zhang J, et al. SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis. Cancer Cell Int. 2020;20(1):188.
  • Cui Y, Qin L, Wu J, et al. SIRT3 enhances glycolysis and proliferation in sirt3-expressing gastric cancer cells. PLoS One. 2015;10(6):e0129834.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.